Satyakiran Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 06-07-2024
- Paid Up Capital ₹ 4.50 M
as on 06-07-2024
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -3.54%
(FY 2021)
- Profit 10.36%
(FY 2021)
- Ebitda 29.55%
(FY 2021)
- Net Worth 2.67%
(FY 2021)
- Total Assets 32.54%
(FY 2021)
About Satyakiran Life Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sahil Aggarwal and Rakesh Aggarwal serve as directors at the Company.
- CIN/LLPIN
U85110DL2005PTC133667
- Company No.
133667
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Mar 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Satyakiran Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sahil Aggarwal  | Director | 06-Feb-2017 | Current |
| Rakesh Aggarwal | Director | 14-Dec-2020 | Current |
Financial Performance and Corporate Structure Insights of Satyakiran Life Sciences.
Satyakiran Life Sciences Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 3.54% decrease. The company also saw a substantial improvement in profitability, with a 10.36% increase in profit. The company's net worth moved up by a moderate rise of 2.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Satyakiran Life Sciences?
In 2019, Satyakiran Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gateway International School Private LimitedActive 24 years 9 monthsSahil Aggarwal and Rakesh Aggarwal are mutual person
Ganga Ice Factory And Cold Storage Private LimitedActive 26 years 5 monthsSahil Aggarwal and Rakesh Aggarwal are mutual person
- Singh Exim Private LimitedActive 24 years 9 months
Sahil Aggarwal and Rakesh Aggarwal are mutual person
- Pardeep Exim Private LimitedActive 24 years 9 months
Sahil Aggarwal and Rakesh Aggarwal are mutual person
- Rsr Education Private LimitedActive 10 years 4 months
Sahil Aggarwal and Rakesh Aggarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Satyakiran Life Sciences?
Unlock and access historical data on people associated with Satyakiran Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Satyakiran Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Satyakiran Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
